Kazia Therapeutics ROCE
Что обозначает ROCE в Kazia Therapeutics?
ROCE Kazia Therapeutics Limited является 0.00%
Какое определение для ROCE?
Рентабельность использованного капитала (ROCE) - это финансовый коэффициент, который измеряет прибыльность компании и эффективность использования ее капитала.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
ROCE компаний в Health Care сектор на ASX по сравнению с Kazia Therapeutics
Что делает Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Компании с roce похож на Kazia Therapeutics
- Omega Alpha Spac имеет ROCE из -0.01%
- The Gap имеет ROCE из -0.01%
- Elemental Royalties Ltd имеет ROCE из -0.01%
- Auburn National Bancorp имеет ROCE из -0.01%
- Galaxy Digital имеет ROCE из -0.01%
- The Gap имеет ROCE из -0.01%
- Kazia Therapeutics имеет ROCE из 0.00%
- Tejon Ranch Co имеет ROCE из 0.01%
- Glen Burnie Bancorp имеет ROCE из 0.02%
- MSP Steel & Power имеет ROCE из 0.02%
- TTL Beteiligungs- und Grundbesitz-AG имеет ROCE из 0.03%
- First Foundation Inc имеет ROCE из 0.03%
- FirstMark Horizon Acquisition имеет ROCE из 0.03%